Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology

D Dobrev, J Heijman, R Hiram, N Li… - Nature Reviews …, 2023 - nature.com
Inflammation has been implicated in atrial fibrillation (AF), a very common and clinically
significant cardiac rhythm disturbance, but its precise role remains poorly understood. Work …

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

M Sweeney, B Corden, SA Cook - EMBO molecular medicine, 2020 - embopress.org
Cardiac fibrosis is central to the pathology of heart failure, particularly heart failure with
preserved ejection fraction (HF p EF). Irrespective of the underlying profibrotic condition (eg …

Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target

K Schimmel, K Ichimura, S Reddy, F Haddad… - Frontiers in …, 2022 - frontiersin.org
Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …

Tranilast: a review of its therapeutic applications

S Darakhshan, AB Pour - Pharmacological research, 2015 - Elsevier
Abstract Tranilast (N-[3′, 4′-dimethoxycinnamoyl]-anthranilic acid) is an analog of a
tryptophan metabolite. Initially, tranilast was identified as an anti-allergic agent, and used in …

Cardiac fibrosis: potential therapeutic targets

S Park, NB Nguyen, A Pezhouman, R Ardehali - Translational Research, 2019 - Elsevier
Cardiovascular disease is a leading cause of mortality in the world and is exacerbated by
the presence of cardiac fibrosis, defined by the accumulation of noncontractile extracellular …

Biomarkers for the identification of cardiac fibroblast and myofibroblast cells

E Tarbit, I Singh, JN Peart, RB Rose'Meyer - Heart failure reviews, 2019 - Springer
Experimental research has recognized the importance of cardiac fibroblast and
myofibroblast cells in heart repair and function. In a normal healthy heart, the cardiac …

Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-β signaling

W Parichatikanond, T Luangmonkong… - Frontiers in …, 2020 - frontiersin.org
Transforming growth factor-β (TGF-β) is a common mediator of cancer progression and
fibrosis. Fibrosis can be a significant pathology in multiple organs, including the heart. In this …

Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia

R Khan, R Sheppard - Immunology, 2006 - Wiley Online Library
The importance of fibrosis in organ pathology and dysfunction appears to be increasingly
relevant to a variety of distinct diseases. In particular, a number of different cardiac …

[HTML][HTML] Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations

GJ Prud'Homme - Laboratory investigation, 2007 - Elsevier
Transforming growth factor β (TGF-β) is a highly pleiotropic cytokine that plays an important
role in wound healing, angiogenesis, immunoregulation and cancer. The cells of the …

[HTML][HTML] Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease

QL Chen, HR Yin, QY He, Y Wang - Biomedicine & Pharmacotherapy, 2021 - Elsevier
The incidence and prevalence of inflammatory bowel disease (IBD) are increasing
worldwide. Current approved medication for IBD treatment in the clinic mainly includes …